DVS Edition Citation

Riiser, A, Stensrud, T, Stang, J & Andersen, L. B. (2020). Can ß2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs. British Journal of Sports Medicine, 54 (22), 1351-1359. Zugriff am 01.04.2022 unter https://doi.org/10.1136/bjsports-2019-100708

APA (7th ed.) Citation

Riiser, A., Stensrud, T., Stang, J., & Andersen, L. B. (2020). Can ß2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs. British Journal of Sports Medicine, 54(22), 1351-1359.

Chicago Style (17th ed.) Citation

Riiser, A., T. Stensrud, J. Stang, and L. B. Andersen. "Can ß2-agonists Have an Ergogenic Effect on Strength, Sprint or Power Performance? Systematic Review and Meta-analysis of RCTs." British Journal of Sports Medicine 54, no. 22 (2020): 1351-1359.

MLA (9th ed.) Citation

Riiser, A., et al. "Can ß2-agonists Have an Ergogenic Effect on Strength, Sprint or Power Performance? Systematic Review and Meta-analysis of RCTs." British Journal of Sports Medicine, vol. 54, no. 22, 2020, pp. 1351-1359.